| B24 | Switch to INSTI more than offset negative effects of weight gain on incidence of insulin resistance in people living with HIV | E-poster | Metabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy) |
| B25 | Combination of high liver and visceral fat predicts diabetes in people living with HIV | E-poster | Hepatic complications (including NASH) |
| B26 | Circulating GDF15 levels are associated with aging, risk of non-AIDS comorbidities and integrated HIV DNA in ART-treated people living with HIV | E-poster | Ageing with HIV (including polypharmacy and frailty) |
| B26 | Sexual minority stress and accelerated cellular aging in treated HIV infection | E-poster | Ageing with HIV (including polypharmacy and frailty) |
| B26 | Prevalence and predictors of hypertension in aging people living with HIV attending care in Zambia | E-poster | Ageing with HIV (including polypharmacy and frailty) |
| B27 | HIV immune reconstitution inflammatory response syndrome and the risk of adverse pregnancy-fetal outcomes among ART naïve women aged 20-49 years in selected public hospitals, Nairobi, Kenya | On-demand oral abstract session | Immune reconstitution disorders and immune reconstitution inflammatory syndrome |
| B28 | Thirty-day hospital readmission rates among North Americans living with HIV, 2005'2015 | E-poster | Other non-communicable diseases |
| B28 | Loss of retinal nerve fiber layer and contrast sensitivity in people living with HIV with well controlled disease | E-poster | Other non-communicable diseases |
| B29 | Attained stature of HIV exposed Ugandan children by 6-18 years of life according to In-utero or peripartum antiretroviral therapy exposure type | E-poster | Other ART complications and adverse reactions |
| B3 | The clinical effects of durably low CD4 counts while virologically suppressed among ART-initiating persons with HIV in Latin America | On-demand oral abstract session | Determinants of HIV progression and disease control |